PubRank

GEM Study Group

Author PubWeight™ 20.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol 2006 1.80
2 Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy. J Clin Oncol 2008 1.53
3 The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev 2006 1.51
4 Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 2007 1.44
5 CDKN2A germline mutations in individuals with cutaneous malignant melanoma. J Invest Dermatol 2007 1.14
6 Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int J Cancer 2011 1.04
7 Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control 2004 1.03
8 Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma. JAMA Oncol 2015 0.95
9 Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas. Ann Surg Oncol 2011 0.94
10 Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study. JAMA Dermatol 2013 0.94
11 MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study. Cancer Causes Control 2010 0.90
12 Inherited genetic variants associated with occurrence of multiple primary melanoma. Cancer Epidemiol Biomarkers Prev 2015 0.88
13 Inherited variation at MC1R and ASIP and association with melanoma-specific survival. Int J Cancer 2014 0.81
14 Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies. BMC Med Res Methodol 2012 0.81
15 Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study. Carcinogenesis 2015 0.78
16 Sun exposure and melanoma survival: a GEM study. Cancer Epidemiol Biomarkers Prev 2014 0.78
17 Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study. Cancer Med 2016 0.77
18 MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors. Pigment Cell Melanoma Res 2014 0.77
19 Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways. J Natl Cancer Inst 2016 0.76
20 No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival. PLoS One 2017 0.75
21 Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma. Int J Cancer 2016 0.75
22 Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma. JAMA Dermatol 2017 0.75
23 Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas. Br J Dermatol 2017 0.75
24 No Association between Pre-diagnosis Exercise and Survival in Patients with High-Risk Primary Melanoma: A Population-Based Study. Pigment Cell Melanoma Res 2017 0.75
25 Associations of MC1R genotype and patient phenotypes with BRAF and NRAS mutations in melanoma. J Invest Dermatol 2017 0.75
26 Inherited Melanoma Risk Variants Associated with Histopathologically Amelanotic Melanoma. J Invest Dermatol 2019 0.75
27 Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: A population-based study. Carcinogenesis 2015 0.75